
Sign up to save your podcasts
Or


Stocks rose today on promising new COVID-19 vaccine data from Moderna Therapeutics — the latest news cycle in which vaccine optimism outpaces the science. Dan is joined by Dr. Richard Besser, former acting director of the CDC and current CEO of the Robert Wood Johnson Foundation, to dig into what Moderna’s report can tell us, what it can’t tell us, what comes next in the vaccine race, and where the CDC fits into the picture.
By Axios4.3
689689 ratings
Stocks rose today on promising new COVID-19 vaccine data from Moderna Therapeutics — the latest news cycle in which vaccine optimism outpaces the science. Dan is joined by Dr. Richard Besser, former acting director of the CDC and current CEO of the Robert Wood Johnson Foundation, to dig into what Moderna’s report can tell us, what it can’t tell us, what comes next in the vaccine race, and where the CDC fits into the picture.

7,588 Listeners

37,428 Listeners

1,361 Listeners

1,049 Listeners

9,526 Listeners

1,515 Listeners

2,004 Listeners

87,274 Listeners

32,324 Listeners

2,135 Listeners

252 Listeners

12,497 Listeners

2,022 Listeners

4,366 Listeners

15,892 Listeners

10,746 Listeners

3,521 Listeners